🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

28+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 28 recruiting trials for “bone-sarcoma”

Phase 1RecruitingNCT07222735 ↗

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

👨‍⚕️ Rebecca Epperly, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT07359053 ↗

MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

🏥 Shanghai 6th People's Hospital📍 1 site📅 Started Dec 2025View details ↗
RecruitingNCT07215611 ↗

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

👨‍⚕️ Shalin S Patel, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT06958107 ↗

LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients

👨‍⚕️ Johann Hsu, MD, Wake Forest University Health Sciences📍 2 sites📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06445166 ↗

Propranolol for the Treatment of Kaposi Sarcoma in Adults

👨‍⚕️ Lee Ratner, M.D., Ph.D., Washington University School of Medicine📍 1 site📅 Started Aug 2025View details ↗
Phase 1, PHASE2RecruitingNCT07066982 ↗

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

🏥 Essen Biotech📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06796543 ↗

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

👨‍⚕️ Sahaja Acharya, MD, SKCCC Johns Hopkins Medical Institution📍 2 sites📅 Started Mar 2025View details ↗
RecruitingNCT06751355 ↗

Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial

👨‍⚕️ Lee Ratner, M.D., Ph.D., Washington University School of Medicine📍 1 site📅 Started Feb 2025View details ↗
Phase 1, PHASE2RecruitingNCT06709495 ↗

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

👨‍⚕️ David Shulman, MD, Dana-Farber Cancer Institute📍 3 sites📅 Started Jan 2025View details ↗
RecruitingNCT06375122 ↗

Natural History Study of Kaposi Sarcoma

👨‍⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06409013 ↗

Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma

👨‍⚕️ Matthew T. Houdek, M.D., Mayo Clinic in Rochester📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT04305691 ↗

Trial of Ixazomib for Kaposi Sarcoma

👨‍⚕️ Erin Reid, MD, AIDS Malignancy Consortium📍 11 sites📅 Started Nov 2023View details ↗
EARLY_Phase 1RecruitingNCT05851456 ↗

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors

🏥 Shanghai Yunying Medical Technology📍 1 site📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT04515459 ↗

Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma

🏥 Institut Claudius Regaud📍 1 site📅 Started Sep 2022View details ↗
NARecruitingNCT05051059 ↗

Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients

👨‍⚕️ Hazem Wafa, Universitaire Ziekenhuizen KU Leuven📍 1 site📅 Started Oct 2021View details ↗
Phase 2RecruitingNCT04698785 ↗

Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

👨‍⚕️ Mehdi BRAHMI, Centre Léon Bérard, Lyon📍 16 sites📅 Started Jul 2021View details ↗
Phase 2RecruitingNCT03993106 ↗

A Study of sEphB4-HSA in Kaposi Sarcoma

👨‍⚕️ Carl Millner, M.D., AIDS Healthcare Foundation📍 3 sites📅 Started Sep 2020View details ↗
Phase 1, PHASE2RecruitingNCT04303117 ↗

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

👨‍⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jul 2020View details ↗
Phase 2RecruitingNCT04072042 ↗

BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma

👨‍⚕️ Weibin Zhang, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Oct 2019View details ↗
RecruitingNCT05373810 ↗

Registration Study Sarcoma

🏥 Radboud University Medical Center📍 2 sites📅 Started Jul 2019View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →